CTIBIOTECH Funding Round

Round summary

CTIBIOTECH has secured €3 million in funding for its CTIONCOTEST™ project, which will leverage 3D bioprinting to create microtumors for cancer research. This funding, backed by France 2030 and Bpifrance, will accelerate the development of this innovative preclinical research tool. The company plans to use these funds to advance its proprietary 3D bioprinting technology and expand its capabilities in cancer research.

Investors (2)

CTIBIOTECH's other rounds